Clinical Trial Management: Cutting Clinical Trial Costs
White Papers & eBooks
Paper 2 of the Clinical Trial Management series
In this White Paper
Solutions to Reduce Spend across Clinical Trial Phases
With drug development costs doubling in the last 20 years, any sort of delay in clinical trials can be costly. Adding one month to a phase III trial adds an average of over $670,000 to the total cost. This whitepaper breaks down the costs associated with clinical trials and proposes solutions to reduce spend across all phases.
What You’ll Learn
Deep Dive on Clinical Trial Costs
- Why clinical trial costs are increasing
- Breakdown of expenses by phase and therapeutic area
- How to reduce overall trial costs
Discover how to reduce clinical trial expenses!
More in this Series
Download White Paper
Submit this form to access the white paper!